V Kan Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 2 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.18 Cr
About V Kan Pharma Solutions
V Kan Pharma Solutions Private Limited (VKPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 November 2022 (Two years and three months 21 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹8.18 Cr.
Vinay Kanodia and Seema Kanodia serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TG2022PTC167950
- Company No.
167950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at V Kan Pharma Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Kanodia  | Director | 02-Nov-2022 | Current |
| Seema Kanodia | Director | 02-Nov-2022 | Current |
Financial Performance of V Kan Pharma Solutions.
Enhance accessibility to V Kan Pharma Solutions's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of V Kan Pharma Solutions?
Unlock access to V Kan Pharma Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED_391923.webp)
Matrix Pharma-Chem (India) Private LimitedVinay Kanodia and Seema Kanodia are mutual person
Medicare Galaxy LlpSeema Kanodia is a mutual person
Charges (Loans)
₹81.82 M
₹0
Charges Breakdown by Lending Institutions
- Others : 8.03 Cr
- Hdfc Bank Limited : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jul 2023 | Hdfc Bank Limited | ₹1.54 M | Open |
| 28 Jun 2023 | Others | ₹8.03 Cr | Open |
How Many Employees Work at V Kan Pharma Solutions?
Unlock and access historical data on people associated with V Kan Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of V Kan Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped V Kan Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.